Antibacterial and anti-biofilm effects of postbiotic mediator derived from Jeotgal isolate Lactiplantibacillus plantarum KMC12 against Streptococcus mutans Authors: Hyunjin Oh, Jihoon Kim, Jaewoo Bai Published: 2026 ABSTRACT ABSTRACTBackgroundDental caries, commonly known as tooth decay, is a progressive breakdown of tooth tissues caused by the biofilm-producing bacteria, Streptococcus mutans. S. mutans plays a primary role in the initiation and progression of dental caries by producing a biofilm called dental plaque.AimThis study aimed to evaluate the antibacterial and anti-biofilm effects of the neutralized postbiotic mediator (nPM) derived from Lactiplantibacillus plantarum KMC12 and to assess its potential as a therapeutic agent against S. mutans.MethodsKMC12 nPM was prepared through centrifugation, filtration and lyophilization. Its antibacterial and anti-biofilm effects were investigated through MIC/MBC assays, membrane permeability tests, biofilm formation quantification, EPS production measurement, RT-qPCR analysis of biofilm-related genes, and cytotoxicity assays using Caco-2 cells.ResultsKMC12 nPM exhibited antibacterial activity with MIC and MBC values of 128 and 256 mg/mL, respectively, and caused approximately 87% membrane damage at 512 mg/mL. Biofilm formation was inhibited by 36% at 256 mg/mL and 83% at 512 mg/mL. Furthermore, KMC12 nPM significantly downregulated gtfB, gtfD, ftf, aguD and atpD gene expression and reduced EPS production without showing cytotoxicity.ConclusionThese results suggest KMC12 nPM as a promising, novel therapeutic agent for inhibiting S. mutans biofilm formation and caries prevention. Introduction Dental caries is one of the most prevalent biofilm-associated oral diseases and is considered a major dental care burden worldwide. The World Health Organization reported that nearly 100% of adults and 60–90% of children have experienced dental caries [1,2]. The latest Global Burden of Disease Study estimates that approximately 3.5 billion people suffer from oral disorders worldwide [3]. Dental caries is caused by over 700 different types of bacterial species. Under normal conditions, these microorganisms coexist without causing harm to the host. However, disruption of this equilibrium may cause oral diseases, such as dental caries, gingivitis, and periodontitis [4]. Among them, Streptococcus mutans is known to play a critical role in causing dental caries [5]. S. mutans binds to the tooth surface and, when exposed to sucrose, begins synthesizing glucans. These glucans provide additional binding sites for planktonic S. mutans, and S. mutans begins to accumulate and develop biofilm. Accumulated cells excrete extracellular polysaccharide (EPS) and acid, which demineralize tooth enamel, eventually leading to gingivitis and periodontitis [1,4]. To prevent dental caries, many chemotherapeutic agents, such as chlorhexidine (CHX) and fluoride, have been reported to have inhibitory effects on the metabolism of bacteria and the adherence of bacterial cells [6,7]. For example, CHX disrupts the bacterial cell membrane to inhibit S. mutans [6]. Since CHX is a cationic molecule, it can bind to the bacterial wall. At low concentrations, CHX alters the bacterial intracellular environment and promotes the release of cytoplasmic components. At high concentrations, it causes the precipitation and coagulation of cytoplasmic proteins. The bactericidal activity that affects bacterial osmotic balance is particularly effective against gram-positive bacteria [6,8]. Fluoride is also an important agent for preventing dental caries. Fluoride exerts its anti-cariogenic effects by inhibiting tooth demineralization, promoting remineralization and inhibiting plaque bacteria [9]. However, chemical agents may cause substantial adverse effects. CHX causes brownish discoloration of teeth, impairs the taste sensation temporarily, accelerates calculus formation, and has been reported to be genotoxic [6,10,11]. Enamel fluorosis occurs when fluoride interacts with mineralizing tissues, causing alterations in the mineralization process [12]. In mild fluorosis, the mineralizing matrix exhibits a localized effect, resulting in the formation of white, opaque striations on the enamel surface. In severe cases, the porosity of the enamel increases, leading to enamel pitting and secondary discoloration. At high fluoride levels, ameloblasts, the enamel-forming cells, are directly affected [13]. Owing to these side effects of chemotherapeutic agents, natural plant compounds have been thoroughly investigated to prevent dental caries [6,14,15]. Natural plant compounds, mainly phytochemicals, have been proven to be major therapeutic agents against dental caries by showing antibacterial and anti-biofilm effects against S. mutans [1,6,14,16]. For example, cinnamaldehyde reduced the viability of S. mutans and biofilm formation [14]. Another study showed that Zingiber officinale, commonly known as ginger, showed an antibacterial effect against S. mutans [10]. However, some natural plant compounds can be toxic to animals, including humans [17]. For example, some extracted polyphenols at high doses might contribute to the development and progression of cancer [18]. Taken together, there remains a need for more effective and non-toxic natural therapeutic agents to replace conventional treatments in combating cariogenic biofilms. To overcome these concerns, several studies have investigated the role of probiotic microorganisms in preventing dental caries [1,6]. Probiotics are defined as ‘live microorganisms that, when administered in adequate amounts, confer a health benefit on the host’ [19]. In recent years, there has been increasing interest in probiotics as a means to prevent dental caries. For example, Lactiplantibacillus plantarum, Lacticaseibacillus rhamnosus GG (LGG), and Limosilactobacillus reuteri have been shown to inhibit the biofilm formation of S. mutans [20,21]. Another study showed that Ligilactobacillus salivarius exhibited antibacterial and anti-biofilm effects against S. mutans. Lactiplantibacillus pentosus showed an inhibitory effect against S. mutans biofilm. Despite their potential benefits in managing dental caries, it is crucial to overcome the limitations of their survival and susceptibility to environmental conditions for practical application [1,22]. Some studies have reported that probiotics could be cariogenic in early childhood [23]. In addition, most probiotic strains, such as Lactobacillus and Bifidobacterium, are known to be acidogenic, which poses a major hurdle for probiotics to be used to control dental caries [22]. Meanwhile, postbiotic mediators (PMs) are defined as products that are produced and released by probiotics [1,19]. They are significantly safe compared to probiotics and more suitable for immunocompromised people, such as the elderly, prematurely born, and newborns [21]. PMs derived from LGG and L. reuteri have been found to inhibit S. mutans biofilm, metabolic activity, and biofilm-related gene expression [22]. Also, Lin et al. [24]. reported the inhibitory effects of Lacticaseibacillus casei Shirota, L. casei LC01, Lacticaseibacillus paracasei Lpc-37, L. plantarum ST-111 and L. rhamnosus HN001 cell-free supernatant (CFS) against S. mutans growth and biofilm formation, and these effects were attributed to their acid-producing ability. However, previous studies have revealed that some acidic metabolites, such as acetic acid and propionic acid can exhibit cytotoxic effects on various human cell lines [25]. Moreover, enamel erosion is caused by acids, which soften the layer of enamel, leading to the loss of enamel and subsequent exposure of dentine [26]. However, most studies have examined PMs that inhibit S. mutans without pH adjustment, and research using neutralized PMs remains limited. Only a few studies have investigated pH-adjusted postbiotics to rule out acid-driven anti-biofilm effects, which are key secondary factors in S. mutans inhibition. Therefore, the current study aimed to assess the antibacterial and anti-biofilm effects of neutralized PM (nPM) obtained from L. plantarum KMC12, a Jeotgal-derived isolate. Unlike previous studies that primarily focused on acidic metabolites, we utilized a strain from a high-salinity environment known for its robust production of antimicrobial postbiotic mediators to evaluate pH-independent inhibitory effects [27]. Moreover, the antibacterial and anti-biofilm mechanism of nPM against S. mutans has been examined. These results can provide scientific evidence and novel insights to develop nPM as an anti-cavity reagent. Materials and methods Bacterial strains, culture media and growth conditions Lactiplantibacillus plantarum KMC12 was isolated from Jeotgal and previously identified using 16S rRNA sequencing analysis in our laboratory. L. plantarum KMC12 was grown in de Man Rogosa Sharpe (MRS) medium (BD Difco, Sparks, MD, USA) at 37 °C for 24 h under static conditions. Streptococcus mutans KCTC 3065 was obtained from the Korean Collection for Type Culture (Daejeon, Republic of Korea) and grown in brain heart infusion (BHI) medium (KisanBio, Inc., Seoul, Republic of Korea) at 37 °C for 24 h under static conditions. All bacterial strains were preserved in 15% glycerol at −80 °C before use. Preparation of KMC12 neutralized postbiotic mediator (nPM) The cell-free supernatant (CFS) of L. plantarum KMC12 was obtained by centrifugation at 11,000 × g at 4 °C for 20 min and filtered through a 0.45 µm membrane filter (Hyundai Micro, Seoul, Republic of Korea) to obtain postbiotic mediators (PM) [28]. Then, the pH of PM was adjusted to physiological conditions (pH 6.5) using 5 N sodium hydroxide (Samchun, Seoul, Republic of Korea) and lyophilized using an Alpha 1–4 LD plus freeze dryer (Martin Christ, Osterode am Harz, Germany) for 72 h at −58 °C before use [29]. The lyophilized neutralized PM (nPM) was resuspended in phosphate-buffered saline (PBS, Dongin Biotech, Seoul, Republic of Korea) at a concentration of 1,024 mg/mL, sterilized using a 0.45 µm membrane filter, and stored at −20 °C until use. Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of KMC12 nPM The MIC of KMC12 nPM was determined by micro-broth dilution assay in 96-well microtiter plates (96-Well Cell Culture Plate, SPL Life Sciences, Pocheon, Republic of Korea) according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [30]. Briefly, 100 µL of BHI broth was added to each well, and 100 µL of the KMC12 nPM stock solution (final concentration: 1,024 mg/mL) was added to the first well of each row. Starting from the first well, 100 µL from each well was serially transferred to the next, resulting in final concentrations ranging from 1 to 512 mg/mL. S. mutans culture was diluted in BHI broth to obtain a 1 × 107 CFU/mL suspension. Then, 5 µL of the diluted bacterial suspension was added to each well and incubated at 37 °C for 24 h. The MIC was defined as the lowest concentration of KMC12 nPM at which no visible bacterial growth was observed. Wells containing only BHI broth and inoculum served as positive controls, while wells containing only BHI broth and KMC12 nPM were used as negative controls. After incubation at 37 °C for 24 h, visible differences in growth were assessed, and the cell density was measured by absorbance at 600 nm using a microtiter plate reader. The lowest concentration that prevented both visible growth and reduced absorbance was determined as the MIC. To determine the MBC of KMC12 nPM against S. mutans, a colony-forming unit (CFU) assay was performed. Briefly, cells from wells at or above the MIC were diluted in PBS and spotted onto BHI agar plates. After incubation at 37 °C for 48 h, viable cell numbers were enumerated by the plate counting method, and the MBC was determined as the lowest concentration that achieved a ≥3-log reduction (99.9%) in S. mutans numbers compared to the control groups [25]. Effect of KMC12 nPM on S. mutans membrane permeability Changes in the S. mutans membrane permeability were assessed by propidium iodide (PI) (Sigma-Aldrich Co., St. Louis, MO, USA) uptake assay. Briefly, S. mutans culture suspensions were diluted in BHI broth to 1 × 108 CFU/mL and were cultured in the presence and absence of KMC12 nPM at 37 °C for 6 h. After treatment, PI dye was added to a final concentration of 20 μM [31], and the suspensions were then incubated at 37 °C for 20 min in the dark. The fluorescence was measured using a microtiter plate reader at the excitation/emission wavelength of 495/615 nm. Finally, the value was normalized with the cell density at OD600 [32]. Inhibitory effect of KMC12 nPM on S. mutans biofilm formation The anti-biofilm activity of different concentrations of KMC12 nPM was conducted on a 96-well microtiter plate. The overnight culture of S. mutans was diluted in fresh BHI broth supplemented with 0.1% sucrose and was transferred to the wells of a 96-well microtiter plate (final concentration of 1 × 106 CFU/well). Then, KMC12 nPM was added into each well at the final concentrations of 256 mg/mL and 512 mg/mL, and the microtiter plate was incubated for biofilm formation (37 °C for 24 h). The wells incubated at 37 °C for 24 h without KMC12 nPM treatment were used as the control group. After incubation, the culture medium in each well was discarded, and the wells were washed twice with sterile PBS to remove the unattached bacteria. S. mutans biofilm was stained with 0.1% crystal violet for 5 min in the dark at room temperature. The stained S. mutans biofilm was washed twice with PBS to remove non-specifically bound crystal violet solution. The biofilm was destained with a mixture of 0.1% acetic acid and 95% ethanol. The amount of biofilm formation by S. mutans was determined by measuring the absorbance at 590 nm using a microtiter plate reader [33]. Quantification of biofilm-related gene expression by real-time quantitative PCR (RT-qPCR) The expression of the biofilm-related genes was conducted according to the method of Ashrafudoulla et al. [34], with slight modifications. The overnight culture of S. mutans was treated with 256 and 512 mg/mL of KMC12 nPM and cultured in 0.1% sucrose supplemented BHI broth at 37 °C for 9 h. For the control group, S. mutans biofilm was formed at 37 °C for 9 h in the absence of KMC12 nPM treatment. After treatment, S. mutans was centrifuged at 11,000 × g at 4 °C for 20 min and washed twice with PBS. The total RNA was extracted using the RNeasy Mini Kit in strict adherence to the manufacturer’s recommendations (Qiagen, Valencia, CA, USA). Total RNA was converted to complementary DNA (cDNA) using the Maxime RT PreMix kit (iNtRON Biotechnology, Seongnam, Republic of Korea). The RT-PCR reaction mixtures (20 µL) contained 10 μL of SYBR Green Real-time PCR Master Mix (Toyobo, Osaka, Japan), 2 μL of template cDNA, 0.8 μL of each pair of primers, and 6.4 μL of nuclease free water was pre-denatured at 94 °C for 30 s and subjected to 35 cycles of denaturation at 94 °C for 10 min, annealing at 56 °C for 10 sec, and extension at 72 °C for 20 sec using the LightCycler® 96 System (Roche, Basel, Switzerland). 16S rRNA, the housekeeping gene, was used as a control. The primers used in the experiment are listed in Table 1. The relative mRNA levels of genes were determined and normalized to the expression of the housekeeping gene (16S rRNA) and quantified following the 2− ΔΔCT analysis method [35]. Table 1.Sequences of primers used for RT-qPCR.GeneGene functionPrimer sequence (5’-3’)ReferenceForwardReverse 16S rRNA Housekeeping geneCCTACGGGAGGCAGCAGTAGCAACAGAGCTTTACGATCCGAAA[36] gtfB Form water insoluble glucansAGCAATGCAGCCAATCTACAAATACGAACTTTGCCGTTATTGTCA gtfD Form soluble glucansTGTCTTGGTGGCCAGATAAACGAACGGTTTGTGCAGCAAGG ftf Form fructansAAATATGAAGGCGGCTACAACGCTTCACCAGTCTTAGCATCCTGAA aguD Promote tolerance to acidic stress by pumping out protonsATCCCGTGAGTGATAGTATTTGCAAGCCACCAACAAGTAAGG atpD Produce alkaline conditions required for acid toleranceCGTGCTCTCTCGCCTGAAATAGACTCACGATAACGCTGCAAGAC Sequences of primers used for RT-qPCR. Determination of the inhibitory effect of KMC12 nPM on S. mutans extracellular polysaccharide (EPS) production The extracellular polysaccharide (EPS) production of S. mutans in the absence or presence of KMC12 nPM was determined by using the Congo red agar method. Briefly, S. mutans culture suspensions were cultured in the absence and presence of different concentrations of KMC12 nPM at 37 °C for 9 h. After treatment, 10 µL of the control, 256 mg/mL, and 512 mg/mL of KMC12 nPM-treated S. mutans cultures were spotted on sterilized paper discs (8 mm, Advantec Toyo Roshi Kaisha, Ltd., Tokyo, Japan), which were placed on a Congo red agar plate, and were incubated at 37 °C for 24 h. The diameter of the black zone that appears around the biofilm represents the EPS produced by S. mutans. The ImageJ program (The National Institute of Health, Bethesda, MD, USA) was used to analyze the black opaque. The Congo red agar plates were prepared by adding 10 mL of autoclaved 0.8% Congo red stock solution in 100 mL of autoclaved BHI containing 1.8% agar and 1% sucrose [37]. Cell culture and treatments The Caco-2 (human colon carcinoma cell line) was supplied by the Korean Cell Line Bank (Seoul, Republic of Korea) and cultured in Dulbecco’s modified Eagle’s medium (DMEM; Welgene, Gyeongsan, Republic of Korea) supplemented with 10% foetal bovine serum (FBS; Gibco, Burlington, ON, Canada) supplemented with 1% antibiotic–antimycotic (Invitrogen, Carlsbad, CA, USA) at 37 °C in a humidified atmosphere containing 5% CO2 [38]. The KMC12 nPM was resuspended in phenol red-free DMEM (Welgene, Gyeongsan, Republic of Korea) containing 10% FBS and 1% antibiotic–antimycotic to the desired concentration before treatment. Cytotoxicity of KMC12 nPM in Caco-2 cells The cytotoxicity of KMC12 nPM was investigated using a CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI, USA). Briefly, 100 µL of Caco-2 cell suspension adjusted to 5 × 105 cells/mL were grown in a 96-well microtiter plate and incubated at 37 °C for 24 h in a humidified atmosphere containing 5% CO2. After incubation, the cells were treated with different concentrations (256 and 512 mg/mL) of KMC12 nPM, while wells only treated with phenol red-free DMEM containing 10% FBS and 1% antibiotic–antimycotic were used as a negative control. The plate was incubated at 37 °C for 24 h. As a positive control, the cells were treated with lysis buffer for 45 min before the end of incubation. After sample treatment, the plate was centrifuged at 600 × g for 6 min to collect the supernatants. A total of 50 µL of the supernatant obtained from centrifugation was transferred to a new 96-well microtiter plate and mixed with 50 µL of CytoTox 96® reagent. The plate was incubated in the dark at 25 °C for 30 min. After incubation, 50 µL of stop solution was added, and the absorbance was measured at 490 nm. The percentage of lactate dehydrogenase (LDH) release (%) was calculated as follows: Cytotoxicity(%)=[SampleLDHreleaseMaximumLDHrelease]×100 Statistical analysis All experiments were performed in triplicate. Data were analyzed using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA, USA). The values are presented as mean ± SD. Statistical significance was determined by a two-tailed t-test or one-way ANOVA, followed by Tukey’s multiple comparison test. Degrees of significance are indicated in the figure captions as follows: *p < 0.05; **p < 0.01; ***p < 0.001. Results Antibacterial activity of KMC12 nPM To evaluate whether KMC12 nPM exhibits antibacterial activity against S. mutans, the MIC and MBC were determined. As a result, the MIC of KMC12 nPM against S. mutans was 128 mg/mL (data not shown). When the dilutions of each cell suspension in the absence or presence of various concentrations of KMC12 nPM were spotted on BHI agar plates, a 3-log reduction was observed at both 256 and 512 mg/mL concentrations of KMC12 nPM. Thus, the minimal concentration (256 mg/mL) that led to a 99.9% reduction in the growth of S. mutans was considered the MBC value for KMC12 nPM. Cell membrane destruction effect of KMC12 nPM The antimicrobial mechanism of KMC12 nPM against S. mutans was evaluated using the PI uptake assay. S. mutans cell suspensions were stained with PI, and the fluorescence intensity was measured. As shown in Figure 1, there was no significant difference (p > 0.05) in cell membrane integrity when 256 mg/mL (1MIC) of KMC12 nPM was treated. However, in the presence of 512 mg/mL (2MIC) of KMC12 nPM, S. mutans stained with PI exhibited approximately 87% enhanced fluorescence intensities, compared to the control group. Therefore, these results showed that KMC12 nPM specifically targeted the cytoplasmic membrane of S. mutans, resulting in membrane damage and a significant increase in PI uptake. Membrane permeation of S. mutans after treatment with KMC12 nPM. S. mutans (1 × 108 CFU/mL) was treated with KMC12 nPM for 6 h at 37 °C. Asterisks (***) indicate a significant difference compared to the control group (p < 0.001). Anti-biofilm activity of KMC12 nPM To evaluate the potential use of KMC12 nPM as a dental caries control agent, the inhibitory effect of KMC12 nPM on the formation of S. mutans biofilms was assessed (Figure 2). The results showed that KMC12 nPM significantly suppressed S. mutans biofilm formation. Compared to the control group, approximately 36 and 83% of S. mutans biofilm formation was inhibited by co-treatment with 256 and 512 mg/mL of KMC12 nPM, respectively. These results suggest that KMC12 nPM is a promising novel agent with strong anti-biofilm activity against S. mutans. Inhibitory effect of KMC12 nPM on the biofilm formation of S. mutans. S. mutans (1 × 106 CFU/mL) was co-incubated with KMC12 nPM for 24 h at 37 °C in the presence of 0.1% sucrose. Asterisks (** and ***) indicate a significant difference compared to the control group (p < 0.01 and p < 0.001, respectively). Effect of KMC12 nPM on the expression levels of biofilm-related genes The molecular mechanism of KMC12 nPM on S. mutans biofilm formation was investigated by examining the expression levels of biofilm-related genes (gtfB, gtfD, ftf, atpD and aguD) after KMC12 nPM treatment. The expression of these genes was downregulated dose-dependently compared to the control group for 9 h (Figure 3). As shown in Figure 3, treatment of 256 mg/mL of KMC12 nPM reduced expressions of gtfB, gtfD, ftf, atpD and aguD by approximately 63%, 67%, 67%, 39% and 46%, respectively, compared to the control group. After being treated with 512 mg/mL of KMC12 nPM, the expressions of gtfB, gtfD, ftf, atpD, and aguD were downregulated by approximately 77%, 79%, 78%, 71% and 67%, respectively. Inhibitory effect of KMC12 nPM on biofilm-associated gene expression. S. mutans (1 × 108 CFU/mL) was treated with KMC12 nPM for 9 h at 37 °C in the presence of 0.1% sucrose. The expression levels of all target genes were normalized using the 16S rRNA as an internal control. Asterisk (***) indicates a significant difference compared to the control group (p < 0.001). Effect of KMC12 nPM on extracellular polysaccharide (EPS) production Previous RT-qPCR results revealed that KMC12 nPM downregulated EPS biosynthesis (Figure 3), and this effect was further validated by EPS quantification assays. As a result, the control group showed clear black staining around the colony, while the groups treated with 256 and 512 mg/mL of KMC12 nPM displayed smaller and less opaque black areas (Figure 4). Inhibitory effect of KMC12 nPM on extracellular polysaccharide (EPS) production. S. mutans (1 × 106 CFU/disc) was treated with KMC12 nPM for 9 h at 37 °C, seeded on Congo red agar plate in the presence of 1% sucrose, and incubated at 37 °C for 24 h in the presence of various concentrations of KMC12 nPM. Asterisks (**) indicate a significant difference compared to the control group (p < 0.01). Cytotoxicity of KMC12 nPM on Caco-2 cells Compared to the control (no treatment with KMC12 nPM), no significant toxicity was observed from Caco-2 cells treated with a concentration of 256 and 512 mg/mL of KMC12 nPM (Figure 5). These results suggested that KMC12 nPM has the potential to be utilized as a safe agent to control S. mutans. Effect of KMC12 nPM on the degree of lactate dehydrogenase (LDH) release from Caco-2 cells. Caco-2 cells were treated with KMC12 nPM (256 and 512 mg/mL) for 24 h. Asterisks (***) indicate a significant difference compared to the positive control (PC) group (p < 0.001). Discussion Currently, there is an increasing interest in the application of PM to prevent dental caries. PM is a metabolite derived from probiotics, such as vitamins, organic acids, short-chain fatty acids, secreted proteins, secreted biosurfactants, bacteriocins and hydrogen peroxides [1,20]. However, some of the studies have shown that PMs derived from probiotics have toxic effects on oral cell lines because of the organic acids they produce. For example, the CFS of the L. rhamnosus Lr-32 strain impaired the viability of gingival epithelial cells at increasing concentrations [25]. Therefore, evaluating the antibacterial effect of neutralized PM adjusted to a pH of 6.5, which is representative of human saliva, may provide further insights into the role of postbiotics in the modulation of dental caries, excluding the influence of organic acids [39]. Our findings showed that KMC12 nPM exhibited significant antibacterial activity against S. mutans. Although the specific substance that exhibits an antibacterial effect is not yet known, previous research has reported that factors secreted by LAB strains, such as organic acid, hydrogen peroxide, bacteriocins, and other active substances, are the main antibacterial substances against S. mutans [40]. The pH adjustment to 6.5 suggested that antibacterial substances, other than organic acid, may be associated with the MIC of KMC12 nPM against S. mutans, which warrants further investigation. Nevertheless, KMC12 nPM demonstrated potential as a therapeutic agent that could play an important role in preventing dental caries. Meanwhile, elucidating the antimicrobial mechanisms of newly developed approaches is essential to facilitate their further application and optimization. PI is a fluorescent probe that intercalates between base pairs of double-stranded DNA in membrane-damaged cells, thus providing a rapid and reliable fluorescence method for monitoring dead bacterial cells damaged by KMC12 nPM [41]. Ito et al [2]. demonstrated that treatment of S. mutans with 64 µg/mL (2MIC) of abietic acid significantly increased the red fluorescence intensity, suggesting bacterial membrane disruption. Furthermore, membrane damage and subsequent bacterial death were observed when S. mutans was treated with L. reuteri CFS, as confirmed by propidium iodide staining [42]. Taken together, our findings indicate that KMC12 nPM possesses potential as a novel antibacterial strategy against dental caries via bacterial cell membrane destruction. A biofilm is the aggregation of microorganisms that are embedded in a self-produced extracellular matrix state and act as an important virulence factor in dental caries [36,43]. When biofilm is formed, it is found to be difficult to eradicate as the bacterial species involved in biofilm formation are highly resistant to antibacterial agents [43]. Therefore, the inhibition of biofilm formation is a key strategy for controlling bacterial colonization and reducing the incidence of dental caries. Gu et al. [44]. showed that the neutralized CFS of L. pentosus MJM60383 inhibited S. mutans biofilm formation by 41.5%. Furthermore, the CFS of Weissella cibaria (W. cibaria) strains exhibited inhibition rates ranging from 55% to 80% against S. mutans biofilm formation [45]. These results demonstrate that KMC12 nPM exhibits relatively strong antibiofilm activity compared to other probiotics previously reported and thus has potential as a novel anti-S. mutans biofilm agent. Both EPS synthesis and acidogenicity by S. mutans promote biofilm formation and demineralization of the tooth surface, thus leading to the formation of dental caries [46]. S. mutans can secrete EPS production-related enzymes such as Gtfs and fructosyltransferase (Ftf), which are encoded by the gtfB, gtfD and ftf genes, respectively, using sucrose as a substrate [47,48]. GtfB mostly synthesizes cell surface insoluble glucans, which contain α-1,3-linked glucans [49,50]. Insoluble glucans have been considered as a crucial virulence factor of S. mutans, since they can facilitate attachment to the tooth surface and promote accumulation with other microorganisms by enhancing the establishment of biofilms [49,50]. GtfD predominantly synthesizes soluble glucans, which allow interactions with salivary proteins in the pellicle [14]. Soluble glucans may be digested and used as a reserve source of energy when exogenous fermentable carbohydrates are exhausted in the oral cavity, which contributes in part to the low pH values observed in cariogenic plaques [49]. In addition, S. mutans decomposes sucrose in the biofilm into fructose and synthesizes polysaccharides such as fructans by polymerizing fructose using Ftf [48]. When EPS is formed by Gtfs and Ftf, it hardens the biofilm, increases the stress tolerance, and plays an important role in biofilm maturation [48,51]. Thus, the inhibition of EPS synthesis-related genes by KMC12 nPM could serve as a preventive strategy for treating dental caries [49,50]. In addition, the ability of S. mutans to produce acid and tolerate low pH is a critical factor in the demineralization of tooth enamel and the formation of dental caries [14]. The atpD gene encodes membrane-bound F1F0-ATPase, which is a proton pump that is involved in acid tolerance ability [37,52]. F1F0-ATPase plays an important role in overcoming acid stress by removing intracellular protons to maintain the intracellular pH [48]. The aguD gene is involved in the agmatine deiminase system (AgDS). Under acidic conditions, acid-tolerant bacteria such as S. mutans produce agmatine, a decarboxylated derivative of arginine, which accumulates in the biofilm of dental plaque. When S. mutans uptakes agmatine, S. mutans converts it to ammonia and ATP. The produced ammonia neutralizes the pH of the cytoplasm, while the ATP generated is utilized to drive proton extrusion through the F1F0-ATPase [53]. Therefore, one possible antibacterial mechanism of KMC12 nPM against S. mutans is the targeting of F1F0-ATPase, which is consistent with the membrane permeability results (Figure 1) [54]. The reduced gene expression of atpD and aguD may lead to a decrease in S. mutans acid tolerance and survival capacity [44]. Our study showed that treatment of 512 mg/mL of KMC12 nPM significantly reduced the expression of S. mutans biofilm-related genes. Previous studies demonstrated that CFSs of W. cibaria strains D29, D30, D31, and B22 significantly reduced the expression of gtfB by 50–59% and ftf by 50–78% [45]. In addition, the CFS of L. paracasei ET-22 decreased the gene expression levels of gtfB by approximately 40–60% compared to the control group [55]. These findings suggested that KMC12 nPM effectively inhibits S. mutans biofilm formation by targeting key genes involved in polysaccharide synthesis (gtfB, gtfD and ftf) and the acid tolerance response (atpD and aguD), respectively [10]. Therefore, our results demonstrated that KMC12 nPM plays a dual role in inhibiting S. mutans biofilm development and accumulation [10]. Since EPS functions as a protective barrier against environmental stress and antibacterial agents, the inhibition of EPS production by KMC12 nPM is important to enhance the efficacy of other antibacterial compounds that specifically target EPS [5,49]. Wolfson et al [37]. showed that N-arachidonoyl ethanolamine treatment dose-dependently reduced the EPS production of S. mutans. Furthermore, Aqawi et al. [5]. showed that the amount of EPS formed around the bacterial colonies was significantly reduced compared to the control when treated with Cannabigerol. Taken together, our results indicate that KMC12 nPM exhibits promising antibiofilm properties that may be further potentiated through combination with other bioactive compounds. Such synergistic approaches could provide an effective strategy for maximizing its application in biofilm control. LDH normally exists in the cytoplasm and is released when the cell membrane is damaged. Unlike apoptotic cells, necrotic cells leak their intracellular components, such as LDH, and can cause inflammation [56]. LDH activity in the cell culture medium is positively correlated with the number of cells undergoing necrosis [57]. Therefore, analyzing LDH leakage is important to determine the cytotoxicity of KMC12 nPM against Caco-2 cells. Although a slight level of LDH release (approximately 30%) was observed at the highest concentration (512 mg/mL) of KMC12 nPM-treated Caco-2 cells, this level is consistent with previous findings (~30% LDH release), suggesting that KMC12 nPM has no notable cytotoxicity [58]. Given its antibacterial activity and non-cytotoxicity, KMC12 nPM can be a promising additive for dental formulations, including toothpastes, gels, and varnishes, which can provide sufficient contact time with cariogenic biofilms [59]. Incorporating KMC12 nPM at its MIC- or MBC-equivalent concentrations (128 and 256 mg/mL, respectively) is potentially viable, considering that conventional dental additives like nano-hydroxyapatite and xylitol are frequently loaded in 10–15% (w/v) [60,61]. Our preliminary data confirmed that L. plantarum KMC12 did not exhibit haemolytic activity (data not shown). Antibiotic susceptibility testing revealed that L. plantarum KMC12 was susceptible to ampicillin, erythromycin, clindamycin, tetracycline and chloramphenicol but resistant to kanamycin, similar to reference strains (LGG and L. plantarum ATCC 8014). Similar to our findings, L. plantarum BG24 and L. plantarum ATCC 14917 have also been reported to be resistant to kanamycin, which inhibits protein synthesis [62,63]. This intrinsic resistance of lactic acid bacteria (LAB) to aminoglycosides, including gentamicin, kanamycin, and streptomycin, is attributed to the absence of cytochrome-mediated electron transport that reduces drug uptake [62,64]. Further genomic analysis is warranted to confirm whether this resistance in KMC12 is intrinsic or acquired. Nevertheless, the MIC values were within or slightly below the microbiological cut-off values defined by the EFSA guidelines, suggesting that L. plantarum KMC12 is a safe probiotic strain [65]. Moreover, L. plantarum has been granted Qualified Presumption of Safety (QPS) status by the European Food Safety Authority and is recognized as ‘Generally Recognized As Safe (GRAS)’ by the U.S. Food and Drug Administration [66]. Consequently, the metabolites secreted by L. plantarum are generally considered safe for therapeutic application [67]. Taken together, these findings substantiate the potential of KMC12 nPM as a safe and effective postbiotic candidate for the prevention and treatment of S. mutans-associated oral diseases. Its dual action in disrupting bacterial membranes and inhibiting biofilm-related gene expression underscores its promise as a novel strategy in the management of dental caries. Conclusion The present study demonstrated that KMC12 nPM possesses antibacterial and anti-biofilm activities against S. mutans. The antibacterial activity of KMC12 nPM appears to be primarily mediated through membrane disruption, which compromises bacterial integrity. In addition, KMC12 nPM significantly downregulated the expression of genes associated with biofilm formation. These results suggested that KMC12 nPM interferes with the active accumulation stages of biofilm formation, thereby hindering the establishment of cariogenic bacterial communities. Moreover, treatment of KMC12 nPM significantly reduced the EPS production by S. mutans, which may provide benefits in the design of combination approaches with other antibacterial agents. Finally, by targeting biofilm formation and bacterial viability without significant cytotoxic effects, KMC12 nPM presents a promising agent for the development of innovative and safe oral care products. In conclusion, the results of this study showed the potential of KMC12 nPM as a therapeutic agent for the treatment and prevention of oral diseases, especially controlling S. mutans, a key pathogen involved in the development of dental caries.